Effect of rituximab on human in vivo antibody immune responses

BACKGROUND: B-lymphocyte depletion with rituximab has been shown to benefit patients with various autoimmune diseases. We have previously demonstrated that this benefit is also apparent in patients with newly diagnosed type 1 diabetes. OBJECTIVES: The effect of rituximab on in vivo antibody response...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Pescovitz, Mark D., Torgerson, Troy R., Ochs, Hans D., Ocheltree, Elizabeth, McGee, Paula, Krause-Steinrauf, Heidi, Lachin, John M., Canniff, Jennifer, Greenbaum, Carla, Herold, Kevan C., Skyler, Jay S., Weinberg, Adriana
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3659395/
https://ncbi.nlm.nih.gov/pubmed/21908031
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2011.08.008
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados